In:
Blood, American Society of Hematology, Vol. 110, No. 11 ( 2007-11-16), p. 4590-4590
Abstract:
Objective: To study the mechanism of proliferation inhibition and apoptosis of MDS-RAEB MUTZ-1 cells by 2-methoxyestradiol(2-ME). Methods: MUTZ-1 cells were treated with different concentrations of 2-ME;cellular proliferation was determined by MTT assay;apoptosis rate was determined with annexinV-FITC/PI double staining and cell cycle was analyzed by flow cytometry (FCM);the changes of morphologic features of MUTZ-1 cells were investigated by cytomorphology with Wright-Giemsa’s staining; lactate dehydrogenises (LD) was determined by Beckman Counter and agarose gel electrophoresis was used to verify whether 2-ME could induce apoptosis in MUTZ-1 cells. Moreover, the activity of telomerase in MUTZ-1 cells was examined by TRAP-ELISA. Results: The results showed that 1∼4μmol/L 2-ME inhibited the proliferation of MUTZ-1 cells in a dose-and time-dependent manner; the typical apoptotic morphological features appeared in MUTZ-1 cells after being treated with 4μmol/L 2-ME for 12hours; the marked DNA ladder pattern of internucleosomal fragmentation was observed after being treated with 4μmol/L 2-ME for 24hours and the up-regulated production of LD was assayed after treatment of 2-ME for 36hours. The number of MUTZ-1 cells of G0/G1 phase and S phase decreased, while the number of G2/M phase increased after MUTZ-1 cells were incubated with 1,2 and 4μmol/L2-ME for 12 hours, respectively(P 〈 0.05). The inhibition effect of telomerase activity was enhanced in a dose- and time- dependent manner. Moreover, telomerase activity was significant negatively correlated with increased apoptosis (r =−0.954, p=0.046) and the number of sustained G2/M phase(r=−0.979, p=0.021) at the corresponding time point, respectively. Conclusions :It is concluded that the mechanism of proliferation inhibition and apoptosis of MUTZ-1 cells induced by 2-ME is probably related with inhibition of telomerase activity and G2/M cell cycle arrest; 2-ME may be a potentially useful, adjunctive anticancer drug in treating myelodysplastic syndrome.
Type of Medium:
Online Resource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood.V110.11.4590.4590
Language:
English
Publisher:
American Society of Hematology
Publication Date:
2007
detail.hit.zdb_id:
1468538-3
detail.hit.zdb_id:
80069-7
